Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
Status:
Completed
Trial end date:
2019-03-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine changes in immune cells and proteins in response to
treatment with two approved therapies for Rheumatoid arthritis (RA), abatacept versus
adalimumab, both given in combination with methotrexate.